• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

延长植入式心脏复律除颤器心律失常检测时间对预后的影响:荟萃分析。

Impact of prolonged implantable cardioverter-defibrillator arrhythmia detection times on outcomes: a meta-analysis.

机构信息

Department of Cardiology, King's College Hospital NHS Foundation Trust, London, United Kingdom.

Department of Cardiology, King's College Hospital NHS Foundation Trust, London, United Kingdom.

出版信息

Heart Rhythm. 2014 May;11(5):828-35. doi: 10.1016/j.hrthm.2014.02.009. Epub 2014 Feb 12.

DOI:10.1016/j.hrthm.2014.02.009
PMID:24530622
Abstract

BACKGROUND

Programming long arrhythmia detection times can reduce the incidence of implantable cardioverter-defibrillator (ICD) shock therapy. However, potential concerns exist regarding the impact on mortality and incidence of syncope.

OBJECTIVE

The purpose of this study was to perform a meta-analysis to better gauge the impact of prolonged arrhythmia detection times on the rates of ICD shock therapy and other adverse outcomes.

METHODS

Electronic databases were systematically searched. We included only prospective studies that examined the impact of programming longer vs shorter ICD arrhythmia detection times on clinical outcomes. Studies that were retrospective, did not have a control group, used historical controls, or did not specifically state the programmed detection times were excluded. Summary estimates of the relative risk (RR) of death, syncope, and appropriate and inappropriate shocks were calculated using random effects models.

RESULTS

Four studies enrolling 4896 patients were identified. During a mean/median follow-up of 12 to 17 months, there were 305 deaths, 106 patients experienced syncope, 264 received an appropriate shock, and 253 an inappropriate shock. In the long detection group there were significant reductions in mortality (RR 0.77, 95% confidence interval [CI] 0.62, 0.96), and inappropriate shocks (RR 0.50, 95% CI 0.39, 0.65), without significant increase in syncope (RR 1.23, 95% CI 0.84, 1.79).

CONCLUSION

Programming long arrhythmia detection times is an important strategy for improving outcomes from ICD therapy. The use of long detection times can significantly decrease the burden of inappropriate shock therapy and all-cause mortality in ICD recipients, without significant increase in syncope.

摘要

背景

编程长的心律失常检测时间可以减少植入式心脏复律除颤器(ICD)电击治疗的发生率。然而,人们对其对死亡率和晕厥发生率的影响存在潜在担忧。

目的

本研究旨在进行荟萃分析,以更好地评估延长心律失常检测时间对 ICD 电击治疗率和其他不良结局的影响。

方法

系统检索电子数据库。我们仅纳入了前瞻性研究,这些研究检查了编程更长 vs 更短的 ICD 心律失常检测时间对临床结局的影响。排除了回顾性研究、没有对照组、使用历史对照或未明确说明编程检测时间的研究。使用随机效应模型计算死亡率、晕厥和适当及不适当电击的相对风险(RR)的汇总估计值。

结果

确定了四项纳入 4896 名患者的研究。在平均/中位数随访 12 至 17 个月期间,有 305 人死亡,106 人出现晕厥,264 人接受了适当电击,253 人接受了不适当电击。在长检测组中,死亡率(RR 0.77,95%置信区间 [CI] 0.62,0.96)和不适当电击(RR 0.50,95% CI 0.39,0.65)显著降低,而晕厥发生率(RR 1.23,95% CI 0.84,1.79)无显著增加。

结论

编程长的心律失常检测时间是改善 ICD 治疗结果的重要策略。使用长检测时间可显著降低 ICD 接受者的不适当电击治疗负担和全因死亡率,而晕厥发生率无显著增加。

相似文献

1
Impact of prolonged implantable cardioverter-defibrillator arrhythmia detection times on outcomes: a meta-analysis.延长植入式心脏复律除颤器心律失常检测时间对预后的影响:荟萃分析。
Heart Rhythm. 2014 May;11(5):828-35. doi: 10.1016/j.hrthm.2014.02.009. Epub 2014 Feb 12.
2
Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.旨在减少不必要的植入式心脏复律除颤器治疗的编程策略对死亡率的影响:系统评价和荟萃分析。
Circ Arrhythm Electrophysiol. 2014 Feb;7(1):164-70. doi: 10.1161/CIRCEP.113.001217. Epub 2014 Jan 20.
3
Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.儿茶酚胺能多形性室性心动过速的除颤治疗结果
Heart Rhythm. 2014 Jan;11(1):58-66. doi: 10.1016/j.hrthm.2013.10.027. Epub 2013 Oct 11.
4
Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.长检测间隔与标准检测间隔对植入式心脏复律除颤器抗心动过速起搏和电击治疗效果的影响:ADVANCE III 随机临床试验。
JAMA. 2013 May 8;309(18):1903-11. doi: 10.1001/jama.2013.4598.
5
Competitive athletes with implantable cardioverter-defibrillators-How to program? Data from the Implantable Cardioverter-Defibrillator Sports Registry.植入式心脏复律除颤器的竞技运动员-如何编程?来自植入式心脏复律除颤器运动登记处的数据。
Heart Rhythm. 2019 Apr;16(4):581-587. doi: 10.1016/j.hrthm.2018.10.032. Epub 2018 Oct 31.
6
Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population.在一级预防患者人群中,采用策略性植入式心脏复律除颤器程控以降低电击治疗负担的安全性和有效性。
Europace. 2014 Feb;16(2):227-34. doi: 10.1093/europace/eut302. Epub 2013 Oct 9.
7
Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications.可植入式心律转复除颤器对遗传性心律失常综合征年轻患者的危害:不适当电击和并发症的系统评价和荟萃分析。
Heart Rhythm. 2016 Feb;13(2):443-54. doi: 10.1016/j.hrthm.2015.09.010. Epub 2015 Sep 15.
8
Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies.比较心律失常综合征和遗传性心肌病患者经静脉与皮下除颤器治疗的效果。
Int J Cardiol. 2021 Jan 15;323:100-105. doi: 10.1016/j.ijcard.2020.08.089. Epub 2020 Aug 29.
9
Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.睡眠呼吸障碍对植入式心脏除颤器用于预防心源性猝死的患者进行适当和不适当植入式心脏复律除颤器治疗的预测作用。
Am J Cardiol. 2013 May 1;111(9):1319-23. doi: 10.1016/j.amjcard.2013.01.277. Epub 2013 Feb 11.
10
Association of Implantable Cardioverter Defibrillator Therapy with All-Cause Mortality-A Systematic Review and Meta-Analysis.植入式心脏复律除颤器治疗与全因死亡率的关联——一项系统评价和荟萃分析
Pacing Clin Electrophysiol. 2016 Jan;39(1):81-8. doi: 10.1111/pace.12766. Epub 2015 Nov 19.

引用本文的文献

1
Management of patients following implantable cardioverter-defibrillator therapy-The importance of a multifaceted approach.植入式心脏复律除颤器治疗后患者的管理——多方面方法的重要性。
J Arrhythm. 2024 Dec 22;41(1):e13204. doi: 10.1002/joa3.13204. eCollection 2025 Feb.
2
Assessment of Antitachycardia Pacing in Primary Prevention Patients: The APPRAISE ATP Randomized Clinical Trial.抗心动过速起搏在一级预防患者中的评估:APPRAISE ATP 随机临床试验。
JAMA. 2024 Nov 26;332(20):1723-1731. doi: 10.1001/jama.2024.16531.
3
Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions.
植入式心脏复律除颤器心动过速治疗:过去、现在与未来方向
J Cardiovasc Dev Dis. 2024 Mar 20;11(3):92. doi: 10.3390/jcdd11030092.
4
Performance of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) in Chinese Population with Primary Prevention Indications: A Prospective Observational Cohort Study.皮下植入式心律转复除颤器(S-ICD)在中国具有初级预防适应证人群中的应用表现:一项前瞻性观察性队列研究。
Med Sci Monit. 2024 Feb 24;30:e942747. doi: 10.12659/MSM.942747.
5
Low Risk of Inappropriate Shock Among Pediatric Patients With an Implantable Cardioverter Defibrillator: A Single Center Experience.儿童植入式心律转复除颤器患者发生不适当电击的风险低:单中心经验。
Pediatr Cardiol. 2024 Dec;45(8):1776-1783. doi: 10.1007/s00246-023-03280-0. Epub 2023 Sep 5.
6
European Society of Cardiology quality indicators for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.欧洲心脏病学会的心室心律失常患者管理和心脏性猝死预防质量指标。
Europace. 2023 Feb 8;25(1):199-210. doi: 10.1093/europace/euac114.
7
Brazilian Guidelines for Cardiac Implantable Electronic Devices - 2023.《巴西心脏植入式电子设备指南 - 2023》
Arq Bras Cardiol. 2023 Jan 23;120(1):e20220892. doi: 10.36660/abc.20220892.
8
Management of ventricular arrhythmias in heart failure: Current perspectives.心力衰竭中心室心律失常的管理:当前观点
Heart Rhythm O2. 2021 Dec 17;2(6Part B):796-806. doi: 10.1016/j.hroo.2021.08.007. eCollection 2021 Dec.
9
Inappropriate ICD Shocks in Pediatric and Congenital Heart Disease Patients.小儿及先天性心脏病患者不适当的植入式心律转复除颤器电击
J Innov Card Rhythm Manag. 2017 Nov 15;8(11):2898-2906. doi: 10.19102/icrm.2017.081104. eCollection 2017 Nov.
10
Contemporary benefit-harm profile over two decades in primary prophylactic ICD-therapy.二十余年来,初级预防 ICD 治疗的当代获益-危害特征。
Clin Cardiol. 2019 Oct;42(10):866-872. doi: 10.1002/clc.23234. Epub 2019 Jul 17.